31 – 40 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
(
- Contribution to journal › Article
-
Mark
Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Objective Observer vs. Patient Motor State Assessments Using the PD Home Diary in Advanced Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Gait and balance among people with de novo vs. mild to moderate Parkinson’s disease
2022) 6th International Conference on Neurology and Brain Disorders (Virtual)(
- Contribution to conference › Abstract
- 2021
-
Mark
Parkinson’s disease in Sweden—resource use and costs by severity
(
- Contribution to journal › Article
-
Mark
Clinical Usefulness of Retropulsion Tests in Persons with Mild to Moderate Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Longitudinal prediction of falls and near falls frequencies in Parkinson's disease:a prospective cohort study
(
- Contribution to journal › Article
-
Mark
The Non-Motor Symptoms Scale in Parkinson’s disease : Validation and use
(
- Contribution to journal › Scientific review
-
Mark
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease : A Structured Review
(
- Contribution to journal › Scientific review
-
Mark
Swedish guidelines for device-aided therapies in Parkinson's disease —Economic evaluation and implementation
(
- Contribution to journal › Article